Real-time enrollment status for this severe combined immunodeficiency clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 11:09 PM UTC
| NCT Number | NCT03538899 |
| Recruiting Status | Recruiting |
| Condition | Severe Combined Immunodeficiency |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of California, San Francisco |
| Last Updated on CT.gov | February 13, 2026 (Feb 13, 2026) |
As of August 29, 2026: Clinical trial NCT03538899 is currently recruiting participants. This phase1 study for severe combined immunodeficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by University of California, San Francisco. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03538899 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03538899 was last updated Feb 13, 2026 (February 13, 2026). HelloStudys verifies this status automatically.